OR WAIT 15 SECS
October 26, 2020
Here’s a preview of the featured content to watch for this week on Drug Topics®.
Walmart filed a pre-emptive suit against 2 government agencies that are threatening to sue Walmart over its pharmacists filling opioid prescriptions.
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
October 22, 2020
Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.
The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.
October 21, 2020
CVS Health is hiring more than 10,000 full-time and part-time pharmacy technicians to meet the demand for flu vaccinations and, in the future, coronavirus disease 2019 (COVID-19) vaccinations.
October 20, 2020
Policymakers have the power to get pharmacy benefit managers under control.
October 19, 2020
The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.
October 16, 2020
Here's the coronavirus-related news from this week that you should know.
